Suppr超能文献

The CXCR6-CXCL16 axis mediates T cell control of polyomavirus infection in the kidney.

作者信息

Lauver Matthew D, Katz Zoe E, Markus Havell, Derosia Nicole M, Jin Ge, Ayers Katelyn N, Butic Arrienne B, Bushey Kaitlyn, Abendroth Catherine S, Liu Dajiang J, Lukacher Aron E

机构信息

Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.

出版信息

PLoS Pathog. 2025 Mar 5;21(3):e1012969. doi: 10.1371/journal.ppat.1012969. eCollection 2025 Mar.

Abstract

BK polyomavirus (PyV) establishes lifelong asymptomatic infections in the reno-urinary system of most humans. BKPyV-associated nephropathy is the leading infectious cause of kidney allograft loss. Using mouse PyV, a natural murine pathogen that also persists in the kidney, we define a dominant chemokine receptor-chemokine axis that directs T cell infiltration of the kidney. We found that CXCR6 was required for CD4+ and CD8+ T cells to be recruited to and retained in the kidney, respectively. Absence of CXCR6 impaired virus control in the kidney. The soluble form of CXCL16 was increased in kidneys of infected mice and in vivo CXCL16 neutralization reduced numbers of virus-specific CD8+ T cells infiltrating the kidney. In vivo administration of IL-12 upregulated CXCR6 expression on virus-specific CD8+ T cells, improved T cell recruitment to the infected kidney, and reduced virus levels. Notably, T cells in kidney biopsies from PyV-associated nephropathy patients express CXCR6 and transcriptional analysis shows significant upregulation of CXCR6 and CXCL16. These findings demonstrate the importance of the CXCR6-CXCL16 axis in regulating T cell responses in the kidney to PyV infection.

摘要

相似文献

1
The CXCR6-CXCL16 axis mediates T cell control of polyomavirus infection in the kidney.
PLoS Pathog. 2025 Mar 5;21(3):e1012969. doi: 10.1371/journal.ppat.1012969. eCollection 2025 Mar.
3
CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.
J Invest Dermatol. 2012 Mar;132(3 Pt 1):626-34. doi: 10.1038/jid.2011.371. Epub 2011 Nov 24.
4
The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Cancer Res. 2008 Jun 15;68(12):4701-8. doi: 10.1158/0008-5472.CAN-08-0482.
5
Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Arthritis Rheum. 2005 Oct;52(10):3004-14. doi: 10.1002/art.21301.
6
CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
PLoS One. 2014 Jun 4;9(6):e99056. doi: 10.1371/journal.pone.0099056. eCollection 2014.
8
The CXCL16-CXCR6 chemokine axis in glial tumors.
J Neuroimmunol. 2013 Jul 15;260(1-2):47-54. doi: 10.1016/j.jneuroim.2013.04.006. Epub 2013 Apr 28.
9
The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease.
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):914-20. doi: 10.1161/ATVBAHA.110.220558. Epub 2011 Jan 13.
10
Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
Clin Nutr. 2013 Oct;32(5):849-54. doi: 10.1016/j.clnu.2013.01.008. Epub 2013 Jan 23.

引用本文的文献

1
Live long and persist: polyomavirus immune evasion in the brain and kidney.
Future Virol. 2025 Jul 9. doi: 10.1080/17460794.2025.2530832.
2
Dynamic remodeling of the pancreas immune landscape in obesity.
Res Sq. 2025 Aug 27:rs.3.rs-7123997. doi: 10.21203/rs.3.rs-7123997/v1.
3
CXCR4 and CXCR6 dually limit T cell entry into the polyomavirus-infected brain.
J Neuroinflammation. 2025 Jun 28;22(1):169. doi: 10.1186/s12974-025-03496-2.
4
Shedding dynamics of a DNA virus population during acute and long-term persistent infection.
PLoS Pathog. 2025 May 23;21(5):e1013083. doi: 10.1371/journal.ppat.1013083. eCollection 2025 May.

本文引用的文献

1
Viral Nephropathies: Core Curriculum 2024.
Am J Kidney Dis. 2024 Dec;84(6):767-779. doi: 10.1053/j.ajkd.2024.06.014. Epub 2024 Oct 10.
2
Intestinal CXCR6 ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression.
Immunity. 2024 Jun 11;57(6):1306-1323.e8. doi: 10.1016/j.immuni.2024.05.004. Epub 2024 May 29.
3
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
Br J Cancer. 2024 Jun;130(12):2016-2026. doi: 10.1038/s41416-024-02702-x. Epub 2024 May 4.
4
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.
Transplantation. 2024 Sep 1;108(9):1834-1866. doi: 10.1097/TP.0000000000004976. Epub 2024 Apr 12.
5
Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation.
Proc Natl Acad Sci U S A. 2023 Oct 3;120(40):e2306761120. doi: 10.1073/pnas.2306761120. Epub 2023 Sep 27.
6
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.
Mol Ther Nucleic Acids. 2023 Jul 19;33:599-616. doi: 10.1016/j.omtn.2023.07.020. eCollection 2023 Sep 12.
9
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.
Cell. 2021 Aug 19;184(17):4512-4530.e22. doi: 10.1016/j.cell.2021.07.015. Epub 2021 Aug 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验